Actively Recruiting
The Effect of Gender-affirmative Measures on Breast Perception in Trans Men
Led by Medical University Innsbruck · Updated on 2026-03-06
100
Participants Needed
1
Research Sites
256 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Breast dysphoria in transmasculine or genderdiverse individuals is a distinct psychological burden associated with depression, anxiety and suicidality. The aim is to systematically investigate the effect of GAHT (gender-affirming hormone therapy) and mastectomy on this form of dysphoria. The primary objective of this study is to analyse and investigate the psychological and physical effects of breast development on trans men or genderdiverse individuals. A secondary objective is to determine the extent to which the stress affects the well-being of trans men depending on the coping strategies used (binding vs. taping).
CONDITIONS
Official Title
The Effect of Gender-affirmative Measures on Breast Perception in Trans Men
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Assigned female at birth (AFAB)
- Not started gender-affirming hormone therapy (GAHT)
- Not undergone mastectomy
You will not qualify if you...
- Currently receiving gender-affirming hormone therapy
- Mastectomy already performed
- Cannot provide informed consent
- Insufficient knowledge of German language
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Medical University Innsbruck
Innsbruck, Austria
Actively Recruiting
Research Team
K
Katharina Feil
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here